Explanatory Note
This Amendment No. 2 (this “Amendment”) amends and supplements the Schedule 13D filed on January 8, 2019, as amended on April 26, 2019, by the Reporting Persons relating to the common stock, par value $0.001 per share (the “Common Stock”), of Liberated Syndication, Inc. (the “Issuer”). Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 is hereby amended and restated as follows:
The shares of Common Stock purchased by Camac Fund were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 1,858,449 shares of Common Stock beneficially owned by Camac Fund is approximately $2,716,141.53, including brokerage commissions. The aggregate purchase price of the 63,385 shares of Common Stock beneficially owned by Mr. McMillan is approximately $94,242, excluding broker commissions.
Item 4. Purpose of Transaction
Item 4 is hereby amended to add the following:
On June 24, 2019, the Board purported to adopt amendments to the Issuer’s bylaws. Among other things, these amendments imposed an “advance notice” requirement for director nominations and proposals of business by stockholders at an annual meeting of stockholders of the Issuer.
In order to protect and enhance the value of their investment in the Issuer, the Reporting Persons believe that it is necessary to take action to reconstitute the Board. Accordingly, on July 11, 2019, Camac Fund delivered a letter (the “Notice”) to the Issuer nominating Eric Shahinian, Michael Cricenti, Simeon McMillan, Adam Pincus and Bradley M. Tirpak (collectively, the “Nominees”) for election to the Board at the Issuer’s 2019 Annual Meeting of Stockholders (the “2019 Annual Meeting”). The Notice also included various proposals of business at the 2019 Annual Meeting to improve the Issuer’s corporate governance. These proposals are consistent with those contained in Camac Fund’s special meeting request statement. The special meeting request statement was provided to stockholders of the Issuer in connection with the Reporting Persons’ efforts to call a special meeting of stockholders of the Issuer.
The Reporting Persons continue to actively pursue the call of a special meeting of stockholders of the Issuer.
Item 5. Interest in Securities of the Issuer
Item 5 is hereby amended and restated as follows:
(a) and (b) The responses of the Reporting Persons to rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Amendment are incorporated by reference. As of 4:00 p.m., Eastern time, on July 11, 2019, (1) Camac Fund beneficially owned 1,858,449 shares of Common Stock, representing approximately 6.3% of the outstanding shares of Common Stock; (2) Mr. McMillan beneficially owned 63,385 shares of Common Stock, representing approximately 0.2% of the outstanding shares of Common Stock; and (3) no other Reporting Person beneficially owned shares of Common Stock.
Page 9